Tiagabine
Tiagabine (trade name Gabitril) is an anticonvulsant medication produced by Cephalon that is used in the treatment of epilepsy. The drug is also used off-label in the treatment of anxiety disorders and panic disorder.
Clinical data | |
---|---|
Pronunciation | /taɪˈæɡəbiːn/ |
Trade names | Gabitril |
AHFS/Drugs.com | Monograph |
MedlinePlus | a698014 |
Pregnancy category |
|
Routes of administration | Oral (tablets) |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 90–95% |
Protein binding | 96% |
Metabolism | Hepatic (CYP450 system, primarily CYP3A) |
Onset of action | Tmax = 45 min |
Elimination half-life | 5–8 hours |
Excretion | Fecal (63%) and renal (25%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H25NO2S2 |
Molar mass | 375.55 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.